Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DOLORA PAIN MANAGEMENT ASSOCIATES, PC

NPI: 1922041276 · WARREN, MI 48088 · Pain Clinic/Center · NPI assigned 06/14/2006

$476K
Total Medicaid Paid
22,217
Total Claims
19,706
Beneficiaries
25
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialKHAN, SAYEED (M.D.)
NPI Enumeration Date06/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,601 $98K
2019 8,060 $145K
2020 4,852 $76K
2021 2,029 $65K
2022 2,373 $79K
2023 113 $5K
2024 189 $9K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,954 2,715 $125K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,371 1,252 $109K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,741 1,611 $101K
62323 721 598 $67K
27096 301 248 $29K
99308 Subsequent nursing facility care, per day, straightforward 448 446 $20K
80305 1,157 1,052 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,382 2,012 $4K
64493 32 25 $4K
77002 155 153 $3K
64494 44 37 $2K
64495 44 37 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 48 30 $2K
20610 25 24 $716.78
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 12 12 $394.56
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,789 1,484 $350.36
J1885 Injection, ketorolac tromethamine, per 15 mg 540 479 $315.01
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 281 260 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 75 71 $0.00
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy 34 34 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 3,710 3,248 $0.00
G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required 3,671 3,223 $0.00
G9584 Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy 163 154 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 486 468 $0.00
G9561 Patients prescribed opiates for longer than six weeks 33 33 $0.00